Viewing Study NCT02716012


Ignite Creation Date: 2025-12-26 @ 10:20 PM
Ignite Modification Date: 2026-01-16 @ 8:23 PM
Study NCT ID: NCT02716012
Status: UNKNOWN
Last Update Posted: 2025-03-10
First Post: 2016-03-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer
Sponsor: Mina Alpha Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module